Cancer survival among adults: US SEER Program, 1988-2001: patient and tumor characteristics.
暂无分享，去创建一个
E. Feuer | A. Mariotto | M. Eisner | N. Howlader | L. Ries | M. Reichman | J. Young | B. Miller | C. Smart | G. Keel | Y. Lin | M. Horner | K. Cronin | L. Gloeckler | D. Stinchcomb | C. Kosary | P. McCarron | T. Murphy | Antoinette Percy-Laurry | M. Reichman | Leyda M. Su Ham | Y. D. Lin | H. Vo | D. Lewis | Gretchen Keel | Marie-Josèphe Horner | Lan Huang | P. Zimmerman | Eric J. Feuer | John L. Young | Gretchen E. Keel | Yi Dan Lin | Marie-Josephe D. Horner | Kathleen Cronin | Leyda Su Ham | Nadia Howlader | Lan Huang | Denise Lewis | Barry Miller | Marsha E. Reichman | Peter McCarron | Trish Murphy | Hong Vo | Philip Zimmerman | Charles R. Smart
[1] S. Robbins,et al. Pathologic basis of disease , 1974 .
[2] C. Catton,et al. Prognostic factors for relapse in stage I testicular seminoma treated with surveillance. , 1997, The Journal of urology.
[3] P. Hall,et al. Risk of second malignant neoplasms among long-term survivors of testicular cancer. , 1997, Journal of the National Cancer Institute.
[4] R. Motzer,et al. Testicular germ-cell cancer. , 1997, The New England journal of medicine.
[5] Jewett Ma,et al. Early stage and advanced seminoma: role of radiation therapy, surgery, and chemotherapy. , 1998 .
[6] D. Sleijfer,et al. Circulating plasma platinum more than 10 years after cisplatin treatment for testicular cancer , 2000, The Lancet.
[7] G. Rustin,et al. Surveillance for stage I testicular germ cell tumours: results and cost benefit analysis of management options. , 2000, European journal of cancer.
[8] Cardiovascular morbidity in long-term survivors of metastatic testicular cancer. , 2001 .
[9] L. Einhorn. Curing metastatic testicular cancer , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[10] K. Pienta,et al. Testicular Cancer , 2009, Nature Reviews Disease Primers.